VALENCIA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and
development of therapeutic products for diabetes, announced today that it will present at the RBC Capital Markets 2016 Healthcare
Conference on Tuesday, February 23, 2016 at 10:00 AM (ET) at The Palace Hotel, in New York, NY.
Presenting from the Company will be its Chief Executive Officer, Matthew Pfeffer.
Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's
website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for
patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as
well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are
sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts
certain other information to the website.
Company Contact: Matthew J. Pfeffer Chief Executive Officer (661) 775-5300 mpfeffer@mannkindcorp.com
